A couple of days ago, I published two posts about the differences in OTC (Over-the-Counter) regulation between China and the U.S., and the requirements for Chinese non-prescription OTC drugs to enter the U.S. market. Since then, I've received numerous inquiries from followers and pharmaceutical manufacturers eager to export-their interest in "Chinese OTC drugs going global" is palpable. Moreover, once you decide to enter the U.S. market, simply preparing the necessary compliance credentials for U.S. market approval is enough to get your product on pharmacy shelves. It's simpler than many assume.
In fact, securing these qualifications for drug exports is a "first-mover advantage"-the first companies to achieve compliance will establish barriers to entry that later competitors will struggle to overcome.
Building on my previous posts, let's dive deeper into this topic to assist Chinese OTC drug exporters.
Key Distinction: FDA Approval vs. NDC Registration for U.S. OTC Drugs
The "FDA Approval" and "NDC Registration" for U.S. OTC drugs are fundamentally different concepts with distinct regulatory natures, legal effects, and scopes of application. Below is a detailed breakdown:
1. NDC Registration ≠ FDA Approval (Core Difference)
a. The Essence of NDC Registration
NDC (National Drug Code) is a product identification code assigned by the FDA to track drug distribution information (e.g., packaging specifications, manufacturers). Companies obtain an NDC by submitting product details to the FDA's electronic system (eDRLS, Electronic Drug Registration and Listing System). This is purely an administrative registration process and does not indicate FDA endorsement of the product's safety or efficacy.
b. The Meaning of FDA Approval
FDA Approval refers to a market authorization granted after rigorous technical review (e.g., clinical trial data, manufacturing processes, labeling compliance) confirming a drug's safety and effectiveness. This process applies only to products requiring pre-approval (e.g., prescription drugs, new drugs, certain medical devices). Most OTC drugs do not require this step (exceptions apply in specific cases).
2. Clarifying Common Misconceptions
Misconception 1: "Having an NDC = FDA Certification"
False. An NDC is merely a registration code and does not signify FDA safety or efficacy review. For example, an acne gel with an NDC can legally be sold, but if its ingredients have not been evaluated by the FDA, it may still be recalled.
Misconception 2: "All OTC Drugs Require FDA Approval"
Most OTC drugs gain market access through OTC Monographs-established FDA guidelines specifying acceptable ingredients, dosages, and labeling. These products do not need separate approval. However, if a product contains new ingredients or new uses, it must submit a New Drug Application (NDA) for FDA approval.
3. Compliance Recommendations for Enterprises
NDC registration is the foundational step for OTC drugs entering the U.S. market. Ensure labels and packaging comply with FDA standards.
Differentiate Product Types:
•
Routine OTC: Complete NDC registration is sufficient for sale (e.g., common cold medicines, topical creams).
•
Special OTC: If the product contains new ingredients,同步 apply for FDA approval (e.g., hand sanitizers with novel antimicrobial agents).
In summary, NDC registration is a mandatory administrative requirement for drug distribution in the U.S., while FDA approval is a market license for high-risk products. Most OTC drugs only need NDC registration, but enterprises must rigorously check if their products require additional approvals to avoid compliance risks arising from conceptual confusion.
